Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China flag China · Delayed Price · Currency is CNY
17.50
+0.74 (4.42%)
Feb 13, 2026, 3:00 PM CST

SHA:688488 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
341.02335.34225.36134.91442.71244.68
Trading Asset Securities
80.18106.18215.75351.64163.31536.31
Cash & Short-Term Investments
421.2441.52441.1486.54606.02781
Cash Growth
-10.83%0.10%-9.34%-19.71%-22.41%502.18%
Accounts Receivable
203.86162.92207.62134.7489.68127.02
Other Receivables
8.340.030.01---
Receivables
212.21162.96207.64134.7489.68127.02
Inventory
245.85254.97184.88156.15114.2788.06
Prepaid Expenses
-----0
Other Current Assets
16.5335.4838.7625.0216.9710.65
Total Current Assets
895.79894.93872.38802.46826.931,007
Property, Plant & Equipment
412.37434.45443.54447.18327.3255.95
Long-Term Investments
78.1869.6150.88148.8158.21.94
Goodwill
171.62171.6213.2413.2413.2413.24
Other Intangible Assets
159.88175.47114.59117.62128.2354.36
Long-Term Deferred Tax Assets
86.9783.8554.2939.0219.327.88
Long-Term Deferred Charges
37.2836.4183.969.1342.9498.88
Other Long-Term Assets
2.853.2413.7418.0918.457.84
Total Assets
1,8451,8701,7471,6561,4351,447
Accounts Payable
102.7937.535.6727.3428.129.93
Accrued Expenses
16.8682.139.235.1120.1120.74
Short-Term Debt
289220.5255.55145.16--
Current Portion of Long-Term Debt
119.74169.0580.070.07--
Current Portion of Leases
-4.223.782.054.23-
Current Income Taxes Payable
14.040.82---3.13
Current Unearned Revenue
5.7313.086.2533.122.438.37
Other Current Liabilities
83.76121.7971.0488.8337.6710.84
Total Current Liabilities
631.92649.06491.57331.6892.5473
Long-Term Debt
71.7490.5169.9460--
Long-Term Leases
4.073.752.961.51.36-
Long-Term Unearned Revenue
45.5449.7450.2956.3725.057.25
Long-Term Deferred Tax Liabilities
9.79.436.287.025.866.72
Total Liabilities
762.97802.48621.03456.57124.8286.97
Common Stock
420.78420.78420.78420420420
Additional Paid-In Capital
887.92883.62888.35886.2873.78873.78
Retained Earnings
-332.19-324.06-184.14-108.0716.1266.26
Comprehensive Income & Other
1.510.550.550.85-0.1-0.19
Total Common Equity
978.03980.891,1261,1991,3101,360
Minority Interest
103.9586.19----
Shareholders' Equity
1,0821,0671,1261,1991,3101,360
Total Liabilities & Equity
1,8451,8701,7471,6561,4351,447
Total Debt
484.55488.03412.3208.775.59-
Net Cash (Debt)
-63.35-46.528.8277.78600.43781
Net Cash Growth
---89.63%-53.74%-23.12%-
Net Cash Per Share
-0.18-0.110.070.671.401.96
Filing Date Shares Outstanding
420.78420.78420.78420420420
Total Common Shares Outstanding
420.78420.78420.78420420420
Working Capital
263.87245.87380.81470.78734.39933.72
Book Value Per Share
2.322.332.672.853.123.24
Tangible Book Value
646.53633.81997.711,0681,1681,292
Tangible Book Value Per Share
1.541.512.372.542.783.08
Buildings
-393.46375.44344.92217.76217.76
Machinery
-260.49221.21198.6125.31118.1
Construction In Progress
-2.183.1236.8295.2317.21
Source: S&P Global Market Intelligence. Standard template. Financial Sources.